avatar
e*e
1
我们是一家大型制药厂,现在有 an in vivo contract job open,目前是一年合同,
可能会延长合同. 要求工作时间比较灵活, 能在晚上8-10 和周末给小鼠给药。这
个工作对未来职业发展很有好处。可以把 CV 和联系方式发给我.
可以站内联系我
In Vivo Research Associate
Job description
We are seeking a highly motivated contract Research Associate with strong
interpersonal communication skills to conduct in vivo studies in mice in our
In Vivo Pharmacology group in San Diego.
Requirements
ALAT/ALATg, or BS degree in a life science with minimum 1-2 years of hands
on laboratory experience in small animal experimentation.
• Proficient in handling mice
• Proficient in administering compounds via various routes (PO, IV,
IP, SC)
• blood collection (via cheek bleed, RO, intra-cardiac)
• necropsy, collection of various tissue samples for analysis.
• Experience with xenografts, immunocompromised mice and live
animal surgery a plus.
• Proficient in data collection/documentation, either in electronic
or hardcopy forms.
• Highly organized, detail oriented, a team player, enthusiastic
about drug discovery, and a strong communicator with strong work ethics.
• This position requires flexible working hours: A regular 5 day
work week will include and require: late shift and include Sat/Sun. BID
dosing schedules are central to the position.
avatar
F*n
2
纽约那个黑窝,不要以为我不知道,兄弟,出来混,都要还的。。

our

【在 e******e 的大作中提到】
: 我们是一家大型制药厂,现在有 an in vivo contract job open,目前是一年合同,
: 可能会延长合同. 要求工作时间比较灵活, 能在晚上8-10 和周末给小鼠给药。这
: 个工作对未来职业发展很有好处。可以把 CV 和联系方式发给我.
: 可以站内联系我
: In Vivo Research Associate
: Job description
: We are seeking a highly motivated contract Research Associate with strong
: interpersonal communication skills to conduct in vivo studies in mice in our
: In Vivo Pharmacology group in San Diego.
: Requirements

avatar
e*e
3
我们是在San diego, 是世界上最好的制药公司。 不太明白什么纽约黑窝.
avatar
x*2
4
Thanks for sharing
would you please elaborate on
这个工作对未来职业发展很有好处?
avatar
e*e
5
It is oncology in vivo position in big pharma. after one or two years
training and working experiences, you can easily find a good job.
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。